Authors: Vakil, NB Go, MF

Citation: Nb. Vakil et Mf. Go, Debating the role of Helicobacter pylori infection, AM J M CARE, 7(1), 2001, pp. S27-S32

Authors: Vakil, NB Shaker, R Johnson, DA Kovacs, T Baerg, RD Hwang, C D'Amico, D Hamelin, B

Citation: Nb. Vakil et al., The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety, ALIM PHARM, 15(7), 2001, pp. 927-935

Authors: Maton, PN Vakil, NB Levine, JG Hwang, C Skammer, W Lundborg, P

Citation: Pn. Maton et al., Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis, DRUG SAFETY, 24(8), 2001, pp. 625-635

Authors: Spiegel, BMR Vakil, NB Ofman, JJ

Citation: Bmr. Spiegel et al., Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: Is sooner better? A systematic review, ARCH IN MED, 161(11), 2001, pp. 1393-1404

Authors: Johnson, DA Benjamin, SB Vakil, NB Goldstein, JL Lamet, M Whipple, J D'Amico, D Hamelin, B

Citation: Da. Johnson et al., Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: A randomized, double-blind, placebo-controlled study of efficacy and safety, AM J GASTRO, 96(1), 2001, pp. 27-34

Authors: Krishnamurthy, P Parlow, MH Schneider, J Burroughs, S Wickland, C Vakil, NB Dunn, BE Phadnis, SH

Citation: P. Krishnamurthy et al., Identification of a novel penicillin-binding protein from Helicobacter pylori, J BACT, 181(16), 1999, pp. 5107-5110